Media Advisory: Infrastructure Announcement in York Region
YORK REGION, ON, Nov. 6, 2020 /CNW/ - Members of the media are invited to attend an important infrastructure event with Helena Jaczek, Member of Parliament for Markham?Stouffville, and Tony van Bynen, Member of Parliament for Newmarket?Aurora, on behalf of the Honourable Catherine McKenna, Minister of Infrastructure and Communities; Wayne Emmerson, York Region Chairman and CEO, and his Worship John Taylor, Mayor of the Town of Newmarket.
Date:
Monday, November 9, 2020
Time:
11:00 a.m. EDT
Location:
York Region Water and Wastewater Operation Centre
380 Bayview Pkwy.
Newmarket, Ontario
COVID-19 protocols apply: face coverings are required for attendees and 2 m social distancing is required. Hand sanitizer will be available at the venue.
Phoenix Motor Inc. , a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced it has surpassed 55 million miles driven across its range of products.Phoenix offers a range of...
Phoenix Motor Inc. , a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced the appointment of Michael Yung as its new Chief Financial Officer (CFO), effective April 17,...
Centamin plc ("Centamin", "Group" or "the Company") (LSE:CEY)QUARTERLY REPORTfor the three months ended 31 March 2024MARTIN HORGAN, CEO, commented: "The scheduled processing of lower-grade ore from the open pit,...
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today announces the formation of a new...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...
